Reference
Han E, et al. Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes. Medicine 95: e2786, No. 6, Feb 2016. Available from: URL: http://dx.doi.org/10.1097/MD.0000000000002786
Rights and permissions
About this article
Cite this article
Rosiglitazone increases risk of bladder cancer. Reactions Weekly 1592, 13 (2016). https://doi.org/10.1007/s40278-016-15441-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-15441-y